Alderman & Co. Survey Reveals a Growing Liquidity Crisis in the Commercial Aviation Industry
DANBURY, Conn., July 14, 2020 /PRNewswire/ -- Alderman & Company®, a specialized provider of investment banking services to the middle market of the global aerospace and defense industry, today published the results of a recent proprietary survey highlighting the growing liquidity crisis in the commercial aviation industry.
In June, Alderman & Company surveyed 65 companies in the middle market of the commercial aviation supply chain. These companies included-but were not limited to-manufacturers, distributors, and service providers (such as maintenance and repair). Key findings included:
Airline passenger traffic is not expected to return to pre-pandemic levels until 2022
Suppliers are looking to cut expenses ahead of future declines
Financing for suppliers is not expected to come from banks
"We wanted to get at the heart of both the micro and macro-economic issues industry stakeholders and government officials are facing in light of COVID-19," said Alderman & Company CEO, Bill Alderman. "The pandemic has caused the most significant downturn in the history of commercial aviation and we want to help companies within the supply chain pivot to cope."
This is the second in a series of surveys the company plans to conduct regarding the pandemic's impact on the commercial aviation industry supply chain. Download the survey, Impending Crisishere.
About Alderman & Company Founded in 2001, Alderman & Company® is a specialized investment bank exclusively providing sell-side M&A advisory services to middle market companies within the global aerospace and defense industry. Our clients include family-owned enterprises, microcap public companies, divisions of large corporations, and portfolio companies of private equity firms. Our services are built on comprehensive industry knowledge and years of process expertise providing business owners value-maximizing solutions for exiting their businesses.
Contact: J&L Communications Jennifer Compton [email protected] (615) 969-4737
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...
Walgreens Boots Alliance, Inc. today announced financial results for the second quarter of fiscal 2024, which ended February 29, 2024.
Chief Executive Officer Tim Wentworth said:
"We're encouraged by our first quarter of U.S. Healthcare positive...
Gilead Sciences, Inc. and Xilio Therapeutics, Inc. today announced an exclusive license agreement to develop and commercialize Xilio's Phase 1 tumor-activated IL-12 program, XTX301.
Xilio Therapeutics is a clinical-stage biotechnology company...
Mannatech, Incorporated , a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its fourth quarter and year ended December 31, 2023.
Fourth Quarter Highlights
Fourth...
Mayfair Gold Corp. ("Mayfair" or the "Company") today announced the start the 2024 environmental field program in support of a potential environmental assessment for the 100% controlled Fenn-Gib project in the Timmins region of Ontario. The program...
OneSoft Solutions Inc. (the "Company" or "OneSoft") , a North American developer of cloud-based business solutions, announces that it will release its Fiscal 2023 financial results after market close on April 1, 2024.OneSoft's CEO...